Where do Dyne Therapeutics, Inc.'s ratios come from?

Every ratio is computed from Dyne Therapeutics, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Returns
Return on equity	-58.9%-3.2pp	-55.7%+5.0pp	-60.7%+0.7pp	-61.3%+2.7pp	-64%+24.0pp
Return on assets	-50.2%-2.6pp	-47.5%+4.3pp	-51.8%+1.3pp	-53.1%+5.9pp	-59.1%+15.1pp
Return on invested capital	-188.2%+12.6pp	-200.8%—	——	——	——
Liquidity
Current ratio	19.9×-2.3×	22.3×+8.8×	13.5×-3.4×	16.8×-3.5×	20.4×+4.7×
Quick ratio	19.9×-2.3×	22.3×+8.8×	13.5×-3.4×	16.8×-3.5×	20.4×+4.7×
Cash ratio	14.7×-3.0×	17.6×+8.1×	9.6×-2.1×	11.7×-2.2×	13.9×+3.6×
Leverage
Debt-to-equity	0.2×0.0×	0.2×0.0×	0.2×0.0×	0.2×+0.2×	0×0.0×
Debt-to-assets	0.2×0.0×	0.1×0.0×	0.1×0.0×	0.2×+0.1×	0×0.0×
Interest coverage	-45.3×—	——	——	——	——
Valuation
Market capitalization	$2.99B-7.1%	$3.22B+79.0%	$1.8B+48.9%	$1.21B+2.1%	$1.18B-50.6%
Enterprise value	$2.41B-3.6%	$2.5B+85.4%	$1.35B+59.5%	$844.31M+15.0%	$734.32M-63.0%
Price / book	3.5×+0.1×	3.3×+0.7×	2.6×+0.5×	2.1×+0.3×	1.8×-2.0×
Free cash flow yield	-14.8%-2.2pp	-12.6%+8.4pp	-21%+8.9pp	-30%-2.7pp	-27.3%-15.0pp
Earnings yield	-15.1%-1.2pp	-13.9%+9.7pp	-23.5%+10.6pp	-34.2%-3.1pp	-31%-17.8pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Dyne Therapeutics, Inc.'s ratios come from?: Every ratio is computed from Dyne Therapeutics, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.